Your browser doesn't support javascript.
loading
[Efficacy analysis of Venetoclax combined with TKI and dexamethasone-containing low-dose chemotherapy for relapsed/refractory Ph+acute B-lymphoblastic leukemia].
Tian, Y; Ai, H; Ji, X; Wei, X D; Song, Y P; Yin, Q S.
Afiliação
  • Tian Y; Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Ai H; Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Ji X; Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Wei XD; Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Song YP; Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Yin QS; Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Zhonghua Yi Xue Za Zhi ; 102(10): 745-748, 2022 Mar 15.
Article em Zh | MEDLINE | ID: mdl-35280020

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Bicíclicos Heterocíclicos com Pontes / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Humans Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Bicíclicos Heterocíclicos com Pontes / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Humans Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China